University of Medicine and Pharmacy Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Nephrology Department, Cho Ray Hospital, Vietnam.
Nephrology (Carlton). 2019 Sep;24(9):958-966. doi: 10.1111/nep.13512. Epub 2019 May 2.
(1) To determine incidence and reasons for transfer from maintenance haemodialysis (HD) to peritoneal dialysis (PD); (2) To compare mortality of HD patients transferred to PD with those who initiated and remained on PD.
A 1:2 matched cohort of ANZDATA included patients dialyzing over 3 months dividing into 2 groups. Group A (HD to PD) was compared to group B (initiated and remained on PD) and matched PD group (Group C). We compared mortality by total time on dialysis regardless of modality.
Of 20 882 patients, there were 911 in group A. The transfer rate from HD to PD was 5%, 6.7% and 7.4% at 1,4 and 8 years, respectively. Median time before switching of patients in Group A was 5.9 (4.0-10.9) months. The commonest reported reason for transfer was patient preference (63.8%). Mortality was significantly worse in Group A if dialysis vintage was ≤6 months and from 12-24 months (P < 0.05), whereas there was no difference in mortality if dialysis vintage was 6-12 months or ≥ 24 months (P = 0.073 and P = 0.153, respectively). Overall, mortality of patients in group A was higher than that in group B after adjusting for age, race, chronic lung disease, peripheral vascular disease, cerebrovascular disease, diabetes, haemoglobin and phosphate (hazard ratio = 1.335, 95% confidence interval = 1.172-1.520).
Haemodialysis patients transferred to PD had higher mortality than those initiated on PD, strengthening the case for PD first policy.
(1) 确定从维持性血液透析(HD)转为腹膜透析(PD)的发生率和原因;(2) 比较转至 PD 的 HD 患者与起始并持续 PD 患者的死亡率。
ANZDATA 包含超过 3 个月透析的患者,将其分为 2 组。A 组(HD 转 PD)与 B 组(起始并持续 PD)和匹配的 PD 组(C 组)进行比较。我们比较了无论透析方式如何,整个透析时间的死亡率。
在 20882 名患者中,A 组有 911 名患者。HD 转 PD 的转归率分别为 1 年、4 年和 8 年时的 5%、6.7%和 7.4%。A 组患者在开始转换前的中位时间为 5.9(4.0-10.9)个月。转至 PD 的最常见报告原因是患者偏好(63.8%)。如果透析龄≤6 个月和 12-24 个月(P<0.05),A 组的死亡率显著更差,而如果透析龄为 6-12 个月或≥24 个月(P=0.073 和 P=0.153),死亡率则没有差异。总体而言,在调整年龄、种族、慢性肺部疾病、外周血管疾病、脑血管疾病、糖尿病、血红蛋白和磷酸盐后,A 组患者的死亡率高于 B 组(危险比=1.335,95%置信区间=1.172-1.520)。
转至 PD 的 HD 患者的死亡率高于起始 PD 的患者,这加强了 PD 优先政策的理由。